Perspective Therapeutics CATX Notes Payable
Notes Payable at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NotesPayableCurrent.
The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's notes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's notes payable?
- Perspective Therapeutics (CATX) reported notes payable of $56K in Q1 2026.
- How has Perspective Therapeutics's notes payable changed year-over-year?
- Perspective Therapeutics's notes payable increased by 5.7% year-over-year, from $53K to $56K.
- What is the long-term trend for Perspective Therapeutics's notes payable?
- Over 2 years (2023 to 2025), Perspective Therapeutics's notes payable has grown at a 6.9% compound annual growth rate (CAGR), from $49K to $56K.
- What does notes payable mean?
- Notes payable represents the total principal amount of debt obligations evidenced by formal written promissory notes. These instruments typically carry specific interest rates and maturity dates, reflecting the company's reliance on debt financing to fund operations or capital expenditures. Monitoring this balance is essential for assessing the company's near-term debt service obligations and overall financial leverage.